19-50467713-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001308429.2(GARIN5A):c.656C>T(p.Thr219Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000219 in 1,599,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001308429.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GARIN5A | NM_001308429.2 | c.656C>T | p.Thr219Ile | missense_variant | 4/5 | ENST00000600100.6 | NP_001295358.1 | |
GARIN5A | NM_138411.3 | c.608C>T | p.Thr203Ile | missense_variant | 4/5 | NP_612420.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARIN5A | ENST00000600100.6 | c.656C>T | p.Thr219Ile | missense_variant | 4/5 | 1 | NM_001308429.2 | ENSP00000472421.2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152196Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000315 AC: 7AN: 222208Hom.: 0 AF XY: 0.0000332 AC XY: 4AN XY: 120334
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1447516Hom.: 0 Cov.: 31 AF XY: 0.0000139 AC XY: 10AN XY: 718750
GnomAD4 genome AF: 0.000118 AC: 18AN: 152196Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | The c.608C>T (p.T203I) alteration is located in exon 4 (coding exon 4) of the FAM71E1 gene. This alteration results from a C to T substitution at nucleotide position 608, causing the threonine (T) at amino acid position 203 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at